Showing results (21-30 of 152) with videos related to
Sort By:
Pageof 16
Journal of Cell Science|March 30, 2006
Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complexLuke M Judge, Miki Haraguchiln, Jeffrey S ChamberlainMuscle & Nerve|June 15, 2010
Sequencing protocols to genotype mdx, mdx(4cv), and mdx(5cv) miceGlen B Banks, Ariana C Combs, Jeffrey S ChamberlainMethods in Molecular Biology (Clifton, N.J.)|October 26, 2017
AAV6 Vector Production and Purification for Muscle Gene TherapyChristine L Halbert, James M Allen, Jeffrey S ChamberlainPlos Genetics|November 11, 2020
Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effectsGlen B Banks, Jeffrey S Chamberlain, Guy L OdomCurrent Pediatrics Reports|June 3, 2014
Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular DystrophyJane T Seto, Niclas E Bengtsson, Jeffrey S ChamberlainMolecular and Cellular Neurosciences|January 28, 2009
Truncated dystrophins can influence neuromuscular synapse structureGlen B Banks, Jeffrey S Chamberlain, Stanley C FroehnerStem Cells and Development|August 10, 2016
Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal MuscleLindsey A Muir, Charles E Murry, Jeffrey S ChamberlainHuman Molecular Genetics|August 1, 2025
Bidirectional role of Costameres in the pathophysiology of mdx skeletal musclesGlen B Banks, Darren R Bisset, Jeffrey S ChamberlainBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 2, 2023
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative ReviewSylwia Szwec, Zuzanna Kapłucha, Jeffrey S Chamberlain, et al.Current Opinion in Genetics & Development|May 5, 2009
Therapy for neuromuscular disordersAndrea L H Arnett, Joel R Chamberlain, Jeffrey S ChamberlainPageof 16